Introduction
Hepatitis C virus (HCV) infection is a serious global public health problem, with approximately 180 million people chronically infected with hepatitis C worldwide (1). HCV is a frequent cause of chronic liver disease, including cirrhosis and hepatocellular carcinoma (2) . RNA transcription errors that occur during replication of the virus play an important role in chronicity. Differences in the genetic sequence resulting from these errors create genotypes of HCV. HCV is classified into 6 genotypes and a large number of subtypes based on their genomic sequences (3) . Genotypes 1-3 have worldwide distribution. Genotype 1 is predominant in northern Europe and North America, and in southern and eastern Europe and Japan. Genotype 2 is less frequently represented than type 1. Genotype 3 is endemic in Southeast Asia and is variably distributed in different countries. Genotype 4 is principally found in the Middle East, Egypt, and central Africa (4) . In Turkey, genotype 1b has been found to be dominant.
Determination of the genotype of HCV is an important parameter that determines the duration and response of antiviral therapy in patients with chronic hepatitis C. Thus, determination of genotype is considered to be costeffective (5) . In this study, HCV genotypes were examined in the Adana and Antakya regions of Turkey. the institutional review board and was conducted in accordance with the provisions of the Declaration of Helsinki and good clinical practice guidelines.
Viral RNA extraction
Viral RNA was extracted from serum samples using a QIAGEN Viral RNA Kit (Milan, Italy) according to the manufacturer's instructions.
Real-time quantitative PCR
HCV-RNA load was determined by quantitative real-time PCR. Quantification of HCV-RNA load in serum samples was performed using the QIAGEN Artus HCV RG RT-PCR Kit (QIAGEN). An aliquot of 20 µL of purified sample isolated from the serum was used for amplification in a total reaction volume of 50 µL. The amplification reaction for each sample and standard was performed in duplicate. Amplification cycling was performed using the Rotor-Gene 6000 device (QIAGEN). Data analysis was performed with the Rotor-Gene software according to the manufacturer's instructions.
Pyrosequencing
Two PCRs were generated for each sample by amplifying 2 different regions of the HCV genome using a One-Step RT-PCR Kit (QIAGEN). PCR-1 and PCR-2 products of approximately 240 bp and 180 bp in length were obtained. PCR products were immobilized on Streptavidin Sepharose (GE) beads. HCV genotypes were determined by pyrosequencing assay using HCV genotype sequencing primers (PyroMark Q24, QIAGEN). Four sequencing primers were used. Aliquots of 2.5 µL of each sequencing primer were added to the immobilized PCR products. For pyrosequencing, the single-stranded PCR amplicon that served as a template was hybridized with sequencing primers and the reaction was started by addition of one of the nucleotides as standard pyrosequencing. Analysis of sequences was performed using the PyroMark Q24 software (QIAGEN). Genotypes were classified according to Simmonds et al. (6) .
Statistics
Analyses were calculated with SPSS 18.0.0 for Windows. Student's t-test was used to assess the significance of genotype rates.
Results
Location, sex, and age characteristics of 639 HCV-RNApositive patients are shown in Table 1 . Of the patients, 214
were male and 101 were female in Adana; 139 were male and 185 were female in Antakya. The mean ages were 47.2 ± 19 years in Adana and 57.1 ± 13.2 years in Antakya.
Genotype distributions of the patients in Adana and Antakya are shown in Table 2 . Distributions of genotypes were different in Antakya and Adana. Genotype 1b was found to be dominant and genotype 2 the second most common type in Antakya. In Adana, genotype 1b was also the most common type, but the incidence was very low. Surprisingly, genotype 3 was the second most common type in Adana, and genotype 2 was ranked third.
In order to understand the reason for these differences between the regions of Antakya and Adana, the genotypes of the patients were also compared by sex. Genotypes 1 and 2 were seen in men and women at the same rate in Antakya. Only genotypes 3 and 4 were found just slightly more often in males (P < 0.05) ( Table 3) .
In contrast, distributions of genotypes of the patients in Adana according to sex were different. In Adana, the rate of genotype 1b was found to be lower (42.52%) in males than in females (P < 0.001). The rate of genotype 3 was also very high (34.58%) in males (P < 0.001). Genotype 2 was ranked third, and again it occurred at a higher rate in males ( Table  4) .
The rates of genotypes 1a, 1b, 2, and 4 in the females of Adana were similar to those in the females of Antakya. The rate of genotype 3 was found to be higher in women in Adana than in women in Antakya (P < 0.001) ( Table 5 ).
Discussion
HCV genotypes are important determinants in the treatment protocols in the treatment of chronic hepatitis C. In addition, changes in the distribution of genotypes are important because they may show interregional transmission according to migration or drug use. In the previous studies within Turkey, genotype 1b has been found to be dominant (Table 6 ). However, the rates of genotypes other than genotype 1b vary compared to those of Turkey overall. Genotype 1a was the most common in İzmir (7, 8) , Ankara (9-11), Diyarbakır (12), and Afyon (13). Genotypes 2 and 3 were the least commonly seen genotypes in Turkey. Genotype 2 was found to be relatively common in Gaziantep (14) , and genotype 3 was found to be relatively common in İstanbul (15) . Genotype 4 has been reported at low rates in many Turkish cities, but very high rates of genotype 4 were observed in Kayseri in recent studies (16, 17) . Our study was conducted in 2 major cities. Distributions of genotypes in Antakya were consistent with the overall distributions in Turkey. The only exception is that the rate of genotype 2 was found to be higher compared to the overall national rate, but it was similar to the rate in Gaziantep (14) . This is likely because Antakya and Gaziantep are geographically close to each other. On the other hand, rates of genotypes 2 and 3 were found to be significantly higher in Adana. These results are very different from the results of Yarkın and Hafta (18), who reported the rates of genotypes 1a, 1b, and 2 as 14.5%, 82.2%, and 3.3% in Adana, respectively. They found no relationship between genotype and sex.
In our study, in the females of Adana, the rate of genotype 3 was significantly higher than in Antakya, even though the rate of genotype 2 was similar to the rate found in Antakya.
The rate of genotype 1b, which was 42.52% in males in Adana, was the lowest rate detected so far in Turkey. Moreover, the rates of genotypes 2 and 3, which were 17.76% and 34.58% in males in Adana, respectively, were the highest rates detected so far in Turkey.
In conclusion, the distribution of HCV genotypes differed in neighboring cities. In Adana, the rate of genotype 1 was found to be low, and the rates of genotypes 2 and 3 were unexpectedly high in men compared to other parts of Turkey. Further analytical studies are needed to uncover the origin of HCV genotypes 2 and 3 as seen in these patients. 
